 Connection
Antonio Jimeno-Largo to Neoplasms
This is a "connection" page, showing publications Antonio Jimeno-Largo has written about Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.471 |
|
|
|
-
Jimeno A, Baranda J, Iams WT, Park JC, Mita M, Gordon MS, Taylor M, Dhani N, Leal AD, Neupane P, Eng C, Yeku O, Mita A, Moser JC, Butler M, Loughhead SM, Jennings J, Miselis NR, Ji RR, Nair N, Kornacker M, Zwirtes RF, Bernstein H, Sharei A. Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors. Invest New Drugs. 2023 04; 41(2):284-295.
Score: 0.258
-
Marsh S, Jimeno A. Tazemetostat for the treatment of multiple types of hematological malignancies and solid tumors. Drugs Today (Barc). 2020 Jun; 56(6):377-387.
Score: 0.213
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|